Abdul Abdirahman
Principal
F-Prime
Principal investing in early-stage B2B software, fintech, and vertical SaaS.
Professional summary
Nihal Sinha is a London-based Partner at F-Prime focused primarily on biotech and life sciences in Europe and the U.S. At F-Prime, he was a member of the founding team of Orchard Therapeutics and an investor in Ensoma, Curie Bio, Charm Therapeutics, Aviado Bio, and T-Therapeutics. Before joining F-Prime in 2013, he worked as a strategy consultant at BCG and as an academic physician at Oxford University and UCL Hospitals.
Selected portfolio companies the partner has backed
Career, education, and skills
12 more profiles